What is the appropriate starting dose of bupropion (Wellbutrin) for treating anxiety?

Bupropion (Wellbutrin) is NOT FDA-approved for anxiety and should be initiated cautiously at 37.5 mg once daily in the morning, increasing by 37.5 mg every 3 days if used off-label for anxiety symptoms, though SSRIs remain the preferred first-line treatment for primary anxiety disorders.

Critical Context: Bupropion's Role in Anxiety

Bupropion lacks FDA approval for any anxiety disorder 1. The FDA-approved indications are major depressive disorder and seasonal affective disorder only 1. This is a crucial starting point—you are using this medication off-label if treating anxiety as the primary condition.

Evidence-Based Starting Dose

When bupropion is used (typically for depression with comorbid anxiety), the evidence supports:

For depression with anxiety symptoms:

• Start: 37.5 mg every morning
• Titration: Increase by 37.5 mg every 3 days
• Target: 150 mg twice daily (maximum 300 mg/day)
• Timing: Give second dose before 3 PM to minimize insomnia 2

Alternative dosing from smoking cessation guidelines (which may inform off-label use):

• Days 1-3: 150 mg once daily
• Day 4 onward: 150 mg twice daily if tolerated
• Maximum: 300 mg per day 3

The Anxiety Paradox: What the Evidence Actually Shows

The clinical concern about bupropion worsening anxiety is not strongly supported by recent evidence, but requires nuanced understanding:

Evidence Supporting Use in Anxiety:

• Comparable efficacy to escitalopram in generalized anxiety disorder at 150-300 mg/day 4
• No significant difference in anxiety outcomes compared to SSRIs in propensity-matched naturalistic study over 12 weeks 5
• May reduce anxiety symptoms in depressed patients with comorbid anxiety, showing comparable efficacy to SSRIs/SNRIs in mild-to-moderate anxiety 6, 7
• Anxiety symptoms improved in major depression trials using both immediate-release and sustained-release formulations 8

Evidence of Caution:

• SSRIs showed modest advantage over bupropion in patients with high baseline anxiety in pooled analyses 6
• Stimulating properties can provoke anxiety, particularly at higher doses 7
• Should NOT be used in agitated patients per older guidelines 2
• Anxiety listed as adverse reaction occurring in 5-7% of patients (vs 3-5% placebo) 1

Practical Algorithm for Decision-Making

Use bupropion for anxiety ONLY when:

1. Primary diagnosis is depression with comorbid anxiety symptoms (not primary anxiety disorder)
2. Patient has failed or cannot tolerate SSRIs/SNRIs (first-line agents)
3. Patient has sexual dysfunction on serotonergic agents (bupropion has lower risk) 1
4. Patient needs smoking cessation alongside mood/anxiety treatment 3
5. Patient is NOT agitated at baseline 2

Avoid bupropion when:

• Primary diagnosis is panic disorder, GAD, or social anxiety (SSRIs preferred)
• Severe anxiety with high baseline scores
• History of seizures (absolute contraindication) 3
• Concurrent MAO inhibitor use 3
• Eating disorders or significant agitation 1

Titration Strategy to Minimize Anxiety Risk

Start low, go slow approach:

1. Week 1: 37.5 mg every morning (or 150 mg if using SR formulation)
2. Week 1-2: Monitor for increased anxiety, agitation, insomnia
3. Week 2: Increase to 75 mg daily (37.5 mg twice daily) OR 150 mg twice daily for SR
4. Week 3-4: Target 150 mg twice daily (300 mg total)
5. Reassess at 4-8 weeks for full therapeutic trial 2

Key monitoring points:

• Anxiety levels (use GAD-7 or similar)
• Sleep quality (insomnia is common, occurs in 13-20% vs 13% placebo) 1
• Agitation or restlessness
• Blood pressure (can increase) 9

Critical Safety Considerations

Seizure risk increases with:

• Doses >300 mg/day (avoid exceeding this) 3, 1
• Rapid dose escalation
• History of head trauma, brain metastases, stroke 3
• Eating disorders (relative contraindication)

Neuropsychiatric monitoring:

• Watch for worsening depression, suicidal ideation, hostility 3, 1
• Risk is similar to other antidepressants, not elevated 3

Renal/hepatic impairment:

• Reduce dose by 50% in moderate-severe renal impairment 9
• Maximum 1 tablet daily in moderate-severe hepatic impairment 9

Bottom Line for Clinical Practice

If you must use bupropion for anxiety symptoms, start at 37.5 mg daily and titrate slowly over 2-3 weeks to 150 mg twice daily (300 mg total). However, recognize this is off-label use—SSRIs remain the evidence-based first-line treatment for primary anxiety disorders. Bupropion's role is best reserved for depression with comorbid mild-to-moderate anxiety, particularly when sexual side effects or smoking cessation are considerations. The historical concern about bupropion worsening anxiety appears overstated in recent evidence, but caution is warranted in highly anxious or agitated patients 6, 7, 5.